|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
The Boston Life Sciences Newsmakers: Civitas, Blend, Forma, & More
|
Erin Kutz |
01/13/12 |
Boston
|
|
Knome Names New CEO, Cuts Deal With Johns Hopkins to Analyze 1,000 Genomes
|
Luke Timmerman |
01/09/12 |
Boston
|
|
NormOxys Secures $600,000 New Round
|
VentureDeal |
11/21/11 |
Boston
|
|
NormOxys Obtains $1,556,353 New Round
|
VentureDeal |
06/24/11 |
Boston
|
|
VC Investment in New England Declines in Second Quarter (Two Out of Three Surveys Say); Top 10 Deals Dominated by Biotech
|
Gregory T. Huang |
07/19/10 |
Boston
|
|
FDA Approves Genzyme Pompe Drug, Vertex Hepatitis C Drug Trial Succeeds, Thermo Fisher Acquires Fermentas, & More Boston-Area Life Sciences News
|
Erin Kutz |
05/28/10 |
Boston
|
|
Logical and Arsenal Get $10M Apiece, Constant Contact Acquires NutshellMail, Avila Gets $209M From Clovis, & More Boston-Area Deals News
|
Erin Kutz |
05/26/10 |
Boston
|
|
NormOxys Pockets $17.5M for Drugs Against Heart Failure, Cancer
|
Luke Timmerman |
05/24/10 |
Boston
|
|
NormOxys Obtains $17,500,000 Series B Funding Round
|
VentureDeal |
05/24/10 |
Boston
|
|
A Graceful Exit for Gloucester, Pink Slips at Sermo, A Half a Billion Bucks for Vertex, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
12/09/09 |
Boston
|
|
NormOxys Emerges from Stealth with New Class of Oxygen Drugs for Cancer, Heart Failure
|
Luke Timmerman |
12/04/09 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.
